Fourier Transformed Infrared Spectroscopy in Macular Surgery
1 other identifier
interventional
50
1 country
1
Brief Summary
Epiretinal membranes (ERM) are disorders leading to vision loss and metamorphopsia. Vitrectomy with membrane peeling has developed to be the gold-standard in treatment of ERM. ERM can be well visualized with spectral domain optical coherence tomography (SD-OCT). The aim of the study is to examine ERM and internal limiting membranes (ILM) exzised during routine macular surgery with fourier transformed infrared spectroscopy (FTIR) and compare results to optic coherence tomography (OCT) findings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
February 22, 2018
CompletedFirst Posted
Study publicly available on registry
March 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedSeptember 29, 2020
September 1, 2020
2.4 years
February 22, 2018
September 28, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
collagen
occurrence of different types of collagen fibres in the excised membranes
3 months
Study Arms (1)
FTIR arm
EXPERIMENTALall excised membranes are examined with FTIR spectroscopy
Interventions
Eligibility Criteria
You may qualify if:
- Idiopathic ERM, lamellar macular holes, full thickness macular holes, diabetic ERM and the indication for surgery (visual symptoms)
- Age 21 and older
- written informed consent for surgery and participation in the study prior to surgery
You may not qualify if:
- Hereditary macular disorders
- In case of pregnancy (pregnancy test will be taken preoperatively in women of reproductive age)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Vienna, 1140, Austria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Oliver Findl, Prof.
VIROS at Hanuschkrankenhaus
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- no masking
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the department of Ophthalmology, principal investigator
Study Record Dates
First Submitted
February 22, 2018
First Posted
March 2, 2018
Study Start
January 1, 2017
Primary Completion
June 1, 2019
Study Completion
June 1, 2019
Last Updated
September 29, 2020
Record last verified: 2020-09